Bruce Sill
About Bruce Sill
Bruce Sill is the Senior Director and Region Lead for Field HEOR at Bristol Myers Squibb, with over 25 years of experience in the healthcare and pharmaceutical industry.
Current Role at Bristol Myers Squibb
Bruce Sill is currently serving as the Senior Director - Region Lead for Field Health Economics and Outcomes Research (HEOR) at Bristol Myers Squibb. In this role, he oversees regional field HEOR activities, offering strategic insight and leadership. His responsibilities include focusing on the economic and quality-of-life outcomes of various therapies, providing data-driven support for the company's therapeutic areas.
Previous Experience at Bristol Myers Squibb
Before his current position, Bruce Sill has held multiple key roles within Bristol Myers Squibb. He served as Group Director - Region Lead, Field HEOR from 2018 to 2022, and prior to that, he was the Director, Field HEOR from 2012 to 2018. Through these roles, he has accumulated extensive experience in guiding clinical and economic research initiatives, fostering a deeper understanding of how various health interventions impact patient outcomes.
Experience at Takeda Pharmaceuticals
From 2006 to 2012, Bruce Sill worked at Takeda Pharmaceuticals as the Executive Manager, Clinical Science and Outcomes. During this time, he managed clinical sciences and outcomes research, accumulating valuable expertise in conducting and overseeing scientific studies aimed at understanding the efficiency and effectiveness of medical treatments.
Roles in Healthcare Management
Bruce Sill’s career includes significant roles in healthcare management. He was the Director of Clinical Programs at CIGNA Healthcare from 2003 to 2006, and Director of Pharmacy Services at The Ohio State University Managed Health Care System from 1997 to 2003. These positions gave him a strong background in managing clinical programs and pharmacy services in complex healthcare settings.
Educational Background
Bruce Sill’s educational qualifications include a PharmD from The Ohio State University (2001-2005), an MS in Hospital Pharmacy Administration from the same institution (1993-1995), and a BS in Pharmacy from the University of Connecticut (1987-1992). His extensive academic background underpins his expertise in pharmacy and healthcare management, providing a solid foundation for his leadership roles in the pharmaceutical industry.